- Home
- MGX vs GRWG Comparison
MGX vs GRWG Comparison
Compare MGX & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- GRWG
- Stock Information
- Founded
- MGX 2018
- GRWG 2008
- Country
- MGX United States
- GRWG United States
- Employees
- MGX N/A
- GRWG N/A
- Industry
- MGX
- GRWG RETAIL: Building Materials
- Sector
- MGX
- GRWG Consumer Discretionary
- Exchange
- MGX NYSE
- GRWG Nasdaq
- Market Cap
- MGX 65.0M
- GRWG 60.6M
- IPO Year
- MGX 2024
- GRWG N/A
- Fundamental
- Price
- MGX $1.52
- GRWG $1.09
- Analyst Decision
- MGX Strong Buy
- GRWG Buy
- Analyst Count
- MGX 4
- GRWG 4
- Target Price
- MGX $14.75
- GRWG $2.75
- AVG Volume (30 Days)
- MGX 354.0K
- GRWG 555.8K
- Earning Date
- MGX 05-16-2025
- GRWG 05-08-2025
- Dividend Yield
- MGX N/A
- GRWG N/A
- EPS Growth
- MGX N/A
- GRWG N/A
- EPS
- MGX N/A
- GRWG N/A
- Revenue
- MGX $52,295,000.00
- GRWG $188,866,000.00
- Revenue This Year
- MGX N/A
- GRWG N/A
- Revenue Next Year
- MGX $6.95
- GRWG $4.97
- P/E Ratio
- MGX N/A
- GRWG N/A
- Revenue Growth
- MGX 16.84
- GRWG N/A
- 52 Week Low
- MGX $1.23
- GRWG $0.82
- 52 Week High
- MGX $8.18
- GRWG $3.15
- Technical
- Relative Strength Index (RSI)
- MGX 49.74
- GRWG 54.13
- Support Level
- MGX $1.40
- GRWG $1.09
- Resistance Level
- MGX $1.64
- GRWG $1.24
- Average True Range (ATR)
- MGX 0.14
- GRWG 0.10
- MACD
- MGX 0.00
- GRWG 0.02
- Stochastic Oscillator
- MGX 48.52
- GRWG 50.23
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.